4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-14-013997
Chief Technology Officer acquired 639,248 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
WACHTER ERIC PHD · Chief Technology Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-03-20 | Exercise or conversion : show line 1 in the form | +25,000 | $0.95 | $23,750 | 5,418,236 | D |
| 2014-03-20 | Exercise or conversion : show line 2 in the form | +14,248 | $0.75 | $10,686 | 5,432,484 | D |
| 2014-03-20 | Exercise or conversion : show line 3 in the form | +600,000 | $0.93 | $558,000 | 6,032,484 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-03-20 | Exercise or conversion : show line 4 in the form Employee Stock Option (Right to buy) | −25,000 | 0 | D |
| 2014-03-20 | Exercise or conversion : show line 5 in the form Employee Stock Option (Right to buy) | −14,248 | 0 | D |
| 2014-03-20 | Exercise or conversion : show line 6 in the form Employee Stock Option (Right to buy) | −600,000 | 0 | D |
Loading xslF345X03/doc1.xml…